(Q35962532)

11 August 2017

1 reference

title

Viral prophylaxis in organ transplant patients (English)

1 reference

11 August 2017

Michelle Slifkin

1

1 reference

11 August 2017

Shira Doron

series ordinal

2

1 reference

11 August 2017

David R Snydman

series ordinal

3

1 reference

11 August 2017

1 January 2004

1 reference

11 August 2017

1 reference

11 August 2017

64

1 reference

11 August 2017

24

1 reference

11 August 2017

2763-2792

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200464240-00004

11 August 2017

0 references

cites work

The economic impact of cytomegalovirus infection after liver transplantation

1 reference

12 December 2020

Viral prophylaxis in combined pancreas-kidney transplant recipients.

1 reference

12 December 2020

Infection in the organ transplant recipient. An overview.

1 reference

12 December 2020

Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation

1 reference

12 December 2020

Post-transplant lymphoproliferative disease

1 reference

12 December 2020

Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation

1 reference

12 December 2020

Successful outcome with a "quintuple approach" of posttransplant lymphoproliferative disorder

1 reference

12 December 2020

Incidence of cytomegalovirus disease in renal transplantation without antilymphocyte induction: is prophylaxis necessary?

1 reference

12 December 2020

EBV-induced post-transplant lymphoproliferative disorder (PTLD)

1 reference

12 December 2020

Defining an optimal regimen for cytomegalovirus prophylaxis in organ transplant recipients

1 reference

12 December 2020

Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin

1 reference

12 December 2020

Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.

1 reference

12 December 2020

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

1 reference

12 December 2020

Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination.

1 reference

12 December 2020

Immunization of pediatric solid organ transplant candidates and recipients

1 reference

12 December 2020

Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Transplantation Database

1 reference

12 December 2020

Community respiratory viral infection in adult lung transplant recipients

1 reference

12 December 2020

Prevention of herpes simplex virus infection by oral acyclovir after cardiac transplantation

1 reference

12 December 2020

Prophylaxis for cytomegalovirus in pancreas transplant recipients using intravenous ganciclovir

1 reference

12 December 2020

Preventing acute rejection, Epstein-Barr virus infection, and posttransplant lymphoproliferative disorders after kidney transplantation: use of aciclovir and mycophenolate mofetil in a steroid-free immunosuppressive protocol

1 reference

12 December 2020

Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients

1 reference

12 December 2020

Hepatitis virus infections in heart transplant recipients: epidemiology, natural history, characteristics, and impact on survival

1 reference

12 December 2020

Influenza pneumonia in thoracic organ transplant recipients : what can we do to avoid it?

1 reference

12 December 2020

Infection in solid organ transplantation.

1 reference

12 December 2020

Management of cytomegalovirus disease with antiviral drugs

1 reference

12 December 2020

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

1 reference

12 December 2020

Hepatitis C virus and organ transplantation

1 reference

12 December 2020

Influenza vaccination does not promote cellular or humoral activation among heart transplant recipients

1 reference

12 December 2020

Definitions of cytomegalovirus infection and disease in transplant recipients

1 reference

12 December 2020

Kidney transplantation in patients with chronic hepatitis B virus infection: is the prognosis worse?

1 reference

12 December 2020

The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.

1 reference

12 December 2020

Prophylactic oral acyclovir after renal transplantation

1 reference

12 December 2020

A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients

1 reference

12 December 2020

Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation.

1 reference

12 December 2020

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

1 reference

12 December 2020

Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses

1 reference

12 December 2020

Ganciclovir prophylaxis for cytomegalovirus infections in pulmonary allograft recipients

1 reference

12 December 2020

Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy

1 reference

12 December 2020

PREEMPTIVE TREATMENT FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE

1 reference

12 December 2020

Reduced doses of hepatitis B immunoglobulin protect against hepatitis B virus infection recurrence after liver transplantation.

1 reference

12 December 2020

Cytomegalovirus infection in heart-lung transplant recipients: risk factors, clinical associations, and response to treatment

1 reference

12 December 2020

The role of adoptive immunotherapy in the prevention and treatment of lymphoproliferative disease following transplantation

1 reference

12 December 2020

Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients

1 reference

12 December 2020

Superior efficacy of oral ganciclovir over oral acyclovir for cytomegalovirus prophylaxis in kidney-pancreas and pancreas alone recipients

1 reference

12 December 2020

History of the cytomegalovirus.

1 reference

12 December 2020

A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.

1 reference

12 December 2020

Clinical patterns and treatment of cytomegalovirus infection after solid-organ transplantation.

1 reference

12 December 2020

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients

1 reference

12 December 2020

Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder

1 reference

12 December 2020

Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center

1 reference

12 December 2020

Cytomegalovirus prevention in combined kidney-pancreas transplantation using acyclovir alone

1 reference

12 December 2020

A comparison of cytomegalovirus and community respiratory viruses in immunocompromised patients

1 reference

12 December 2020

Viral complications after transplantation

1 reference

12 December 2020

Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression

1 reference

12 December 2020

A prospective study in heart and lung transplant recipients correlating persistent Epstein-Barr virus infection with clinical events

1 reference

12 December 2020

Orthomyxoviral and paramyxoviral infections in transplant patients.

1 reference

12 December 2020

The immunogenicity of influenza virus vaccine in solid organ transplant recipients

1 reference

12 December 2020

Late complications after cardiac transplantation

1 reference

12 December 2020

Cytomegalovirus prophylaxis in solid organ transplant recipients: the issues

1 reference

12 December 2020

Prevention of symptomatic infection by herpesvirus in patients after heart transplantation

1 reference

12 December 2020

Cytomegalovirus infection and graft rejection in renal transplantation

1 reference

12 December 2020

High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial

1 reference

12 December 2020

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

1 reference

12 December 2020

Prevention of cytomegalovirus disease in recipients of solid-organ transplants

1 reference

12 December 2020

Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation

1 reference

12 December 2020

Epstein Barr virus associated posttransplant lymphoproliferative disease after intestinal transplantation

1 reference

12 December 2020

High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy

1 reference

12 December 2020

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

1 reference

12 December 2020

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

1 reference

12 December 2020

Leads from the MMWR. Varicella-zoster immune globulin for the prevention of chickenpox

1 reference

12 December 2020

Epstein-Barr virus infection in renal transplant recipients. Effects of antithymocyte globulin and interferon

1 reference

12 December 2020

Measurement of Epstein-Barr Virus DNA Loads in Whole Blood and Plasma by TaqMan PCR and in Peripheral Blood Lymphocytes by Competitive PCR

1 reference

12 December 2020

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

1 reference

12 December 2020

Infection in organ-transplant recipients

1 reference

12 December 2020

Randomized comparison of ganciclovir plus intravenous immune globulin (IVIG) with IVIG alone for prevention of primary cytomegalovirus disease in children receiving liver transplants

1 reference

12 December 2020

Costs and Outcomes of Prolonged Cytomegalovirus Prophylaxis to Cover the Enhanced Immunosuppression Phase Following Lung Transplantation

1 reference

12 December 2020

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

1 reference

12 December 2020

Prophylaxis against herpesvirus infections in transplant recipients

1 reference

12 December 2020

Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir

1 reference

12 December 2020

Chemotherapeutic control of influenza

1 reference

12 December 2020

Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections

1 reference

12 December 2020

Outcomes of lung transplantation using three different cytomegalovirus prophylactic regimens

1 reference

12 December 2020

Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells

1 reference

12 December 2020

Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation

1 reference

12 December 2020

Transmission of fatal herpes simplex infection through renal transplantation

1 reference

12 December 2020

Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation

1 reference

12 December 2020

A low incidence of posttransplant lymphoproliferative disorder in 109 lung transplant recipients

1 reference

12 December 2020

Preemptive therapy: Epstein-Barr virus.

1 reference

12 December 2020

Cytomegalovirus prophylaxis by ganciclovir followed by high-dose acyclovir in renal transplantation: a randomized, controlled trial

1 reference

12 December 2020

Posttransplant lymphoproliferative disorders and Epstein-Barr virus prophylaxis.

1 reference

12 December 2020

Effective oral ganciclovir prophylaxis against cytomegalovirus disease in heart transplant recipients

1 reference

12 December 2020

Ganciclovir for prophylaxis of CMV disease after pancreas/kidney transplantation

1 reference

12 December 2020

Preemptive ganciclovir therapy in cytomegalovirus-seropositive renal transplants recipients

1 reference

12 December 2020

Prevention and treatment of influenza in immunocompromised patients

1 reference

12 December 2020

Infectious complications in solid organ transplant recipients

1 reference

12 December 2020

Analysis of Infectious Complications Occurring After Solid-Organ Transplantation

1 reference

12 December 2020

Comparison of PCR, antigenemia assay, and rapid blood culture for detection and prevention of cytomegalovirus disease after lung transplantation

1 reference

12 December 2020

Treatment of recurrent hepatitis B infection in liver transplant recipients

1 reference

12 December 2020

Influenza virus neuraminidase inhibitors

1 reference

12 December 2020

Prevention of recurrent herpes infection after renal transplantation by low-dose oral acyclovir

1 reference

12 December 2020

European Best Practice Guidelines for Renal Transplantation (part 1)

1 reference

12 December 2020

Transmission of infection with herpes simplex virus by renal transplantation

1 reference

12 December 2020

Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients

1 reference

12 December 2020

Possible transmission of herpes simplex virus by organ transplantation

1 reference

12 December 2020

Cytomegalovirus viremia in lung transplant recipients receiving ganciclovir and immune globulin

1 reference

12 December 2020

Varicella-zoster virus hepatitis and a suggested management plan for prevention of VZV infection in adult liver transplant recipients

1 reference

12 December 2020

Efficacy of a 6-week prophylactic ganciclovir regimen and the role of serial cytomegalovirus antibody testing in lung transplant recipients

1 reference

12 December 2020

Influenza pneumonia in lung transplant recipients: clinical features and association with bronchiolitis obliterans syndrome

1 reference

12 December 2020

A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients

1 reference

12 December 2020

Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients

1 reference

12 December 2020

Post-transplantation lymphoproliferative disease

1 reference

12 December 2020

Cytomegalovirus infection following liver transplantation: review of the literature

1 reference

12 December 2020

European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group.

1 reference

12 December 2020

Ganciclovir/acyclovir prophylaxis reduces the incidence of cytomegalovirus infections in pancreas transplant recipients

1 reference

12 December 2020

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

1 reference

12 December 2020

Use of cytomegalovirus (CMV) hyperimmune globulin for prevention of CMV disease in CMV-seropositive lung transplant recipients

1 reference

12 December 2020

Efficacy and cost effectiveness of oral ganciclovir in the prevention of cytomegalovirus disease after lung transplantation

1 reference

12 December 2020

Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections

1 reference

12 December 2020

Ganciclovir prophylaxis decreases frequency and severity of cytomegalovirus disease in seropositive liver transplant recipients treated with OKT3 monoclonal antibodies

1 reference

12 December 2020

Management of recurrent hepatitis C after liver transplantation: a concise review

1 reference

12 December 2020

A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal Allografts

1 reference

12 December 2020

Diseases Produced by Cytomegaloviruses

1 reference

12 December 2020

Effect of CMV serology on outcome after clinical intestinal transplantation.

1 reference

12 December 2020

Viral infections in organ transplantation

1 reference

12 December 2020

Pretransplantation assessment of the risk of lymphoproliferative disorder

1 reference

12 December 2020

Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naïve lung transplant recipient

1 reference

12 December 2020

Evolving experience of hepatitis B virus prophylaxis in liver transplantation

1 reference

12 December 2020

Semiquantitative Epstein-Barr virus polymerase chain reaction analysis of peripheral blood from organ transplant patients and risk for the development of lymphoproliferative disease

1 reference

12 December 2020

Prospective randomized trial of efficacy of ganciclovir versus that of anti-cytomegalovirus (CMV) immunoglobulin to prevent CMV disease in CMV-seropositive heart transplant recipients treated with OKT3.

1 reference

12 December 2020

Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children

1 reference

12 December 2020

Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen

1 reference

12 December 2020

Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial

1 reference

12 December 2020

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients

1 reference

12 December 2020

Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients

1 reference

12 December 2020

Infections in solid-organ transplant recipients

1 reference

12 December 2020

The recipient origin of posttransplant lymphoproliferative disorders in pulmonary transplant patients. A report of three cases

1 reference

12 December 2020

A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients

1 reference

12 December 2020

10.2165/00003495-200464240-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference